Dolanc B, Morscher E
Nouv Presse Med. 1982 Aug 28;11(33):2500-2.
137 out-patients suffering from osteoarthritis of the spine were treated for two-weeks by pirprofen (600 mg/day), indomethacin (75 mg/day), or placebo. At the end of the trial, spontaneous pain disappeared in 47% of patients in the pirprofen group, 38% in the indomethacin group, and 17% in the placebo group. The efficacy of pirprofen and indomethacin, compared to the placebo, is demonstrated with respect to both spontaneous pain (p less than 0,01) and functional disorders (p less than 0,05). Side effects, especially digestive, were noted in 29% of patients treated by pirprofen, 33% of those treated by indomethacin and 17% of those on placebo. Tolerance was satisfactory in 86%, 80% and 90% of patients. Pirprofen is thus judged an effective drug for the treatment of osteoarthritis of the spine.
137例脊柱骨关节炎门诊患者接受了为期两周的治疗,分别使用吡洛芬(600毫克/天)、吲哚美辛(75毫克/天)或安慰剂。试验结束时,吡洛芬组47%的患者自发疼痛消失,吲哚美辛组为38%,安慰剂组为17%。与安慰剂相比,吡洛芬和吲哚美辛在自发疼痛(p<0.01)和功能障碍(p<0.05)方面均显示出疗效。使用吡洛芬治疗的患者中29%出现副作用,尤其是消化系统副作用;使用吲哚美辛治疗的患者中这一比例为33%,使用安慰剂的患者中为17%。患者耐受性良好的比例分别为86%、80%和90%。因此,吡洛芬被判定为治疗脊柱骨关节炎的有效药物。